Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
GENOCEA BIOSCIENCES, INC. has filed 635 SEC EDGAR filings since 25 Feb 2009

SEC filing history

Showing 201-225 of 634 matching filings.

Per page
25
Current page
9
8-K File 001-36289

8-K

Filing date
13 Feb 2020
Reporting date
13 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36289

8-K

Filing date
13 Jan 2020
Reporting date
13 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36289

8-K

Filing date
19 Nov 2019
Reporting date
19 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-225086

424B5

Filing date
08 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36289

8-K

Filing date
05 Nov 2019
Reporting date
05 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-225086

424B5

Filing date
24 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36289

8-K

Filing date
24 Oct 2019
Reporting date
24 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36289

8-K

Filing date
25 Jul 2019
Reporting date
25 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Jul 2019
Reporting date
18 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Jul 2019
Reporting date
18 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Jul 2019
Reporting date
18 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Jul 2019
Reporting date
18 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Jul 2019
Reporting date
18 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Jul 2019
Reporting date
18 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Jul 2019
Reporting date
18 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87984

NEW ENTERPRISE ASSOCIATES 16, L.P. - GENOCEA BIOSCIENCES 13D/A (#2)

Filing date
28 Jun 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Jun 2019
Reporting date
24 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Jun 2019
Reporting date
24 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Jun 2019
Reporting date
24 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Jun 2019
Reporting date
24 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Jun 2019
Reporting date
24 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Jun 2019
Reporting date
24 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Jun 2019
Reporting date
24 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .